HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup

STAT+: Trump administration pursues more durable changes to science policy after setbacks in court

The White House has proposed sweeping changes to the bedrock regulation undergirding all federal contracts, empowering the executive branch to direct research, terminate grants, and external scientific reviews.

By STAT News · Jul 8, 2026 · via STAT News
STAT+: Trump administration pursues more durable changes to science policy after setbacks in court

Image: STAT News

This is an aggregated industry headline. Read the full story at STAT News

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Novartis is executing more layoffs at its U.S. headquarters in East Hanover, New Jersey, handing 322 employees…
Jul 8, 2026
The WeekFierceBiotech ↗
AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challeng…
Jul 8, 2026
FDA Clears Casgevy Use for Children as Young as Two
The WeekBriefing
Vertex’s Casgevy can now treat sickle cell disease and transfusion-dependent beta thalassemia in patients aged…
Jul 8, 2026